表紙
市場調查報告書

數位健康:糖尿病應用程式與虛擬指導

Digital Health: Diabetes Apps and Virtual Coaching

出版商 Datamonitor Healthcare 商品編碼 930636
出版日期 內容資訊 英文 68 Pages
商品交期: 最快1-2個工作天內
價格
數位健康:糖尿病應用程式與虛擬指導 Digital Health: Diabetes Apps and Virtual Coaching
出版日期: 2020年03月10日內容資訊: 英文 68 Pages
簡介

今後10年活用智慧型手機支援型的數位健康技術,產生改善糖尿病的可能性,讓糖尿病管理市場為之一變,也預期削減醫療費。

本報告提供糖尿病管理的數位健康的市場相關分析,糖尿病的主要管理手段和目標指標,主要的解決方案的明細與特徵 - 糖尿病管理應用程式,虛擬指導,血統監測設備等 -、主要企業、產品一覽,今後的市場規模趨勢預測,未來技術開發、市場成長可能性等資訊彙整,為您概述為以下內容。

目錄

摘要整理

第1章 糖尿病概要

  • 第一型糖尿病
  • 第二型糖尿病
  • 糖尿病的盛行率:今後25年增加50%
  • 併發症:嚴格的血糖控制預防併發症
  • 預防
  • 參考文獻

第2章 為了達成血糖控制的新指南

  • Ac1 - ADA的目標價值:糖尿病相關的醫療標準 (2019年)
  • 血糖的自我監視的重要性
  • DCCT的研究
  • 血糖管理目標的ADA的新指南:範圍內
  • Medtronic的TIR的目標
  • 參考文獻

第3章 血糖監測系統和,智慧型手機主導的糖尿病應用程式的登場

  • Ascensia
  • DarioHealth
  • LifeScan
  • Welldoc's BlueStar for diabetes
  • Glooko
  • mySugr
  • 參考文獻

第4章 虛擬糖尿病指導

  • Lark Technologies
  • Livongo
  • Onduo
  • One Drop
  • Virta Health Lark Technologies
  • 參考文獻

第5章 創新的持續血統監測設備

  • Abbott
  • Dexcom
  • Medtronic
  • Nemaura Medical
  • Senseonics
  • 參考文獻

第6章 臨床資料:數位健康對糖尿病的改善有用嗎?

  • HbA1c的有意義的減少
  • 糖尿病應用程式/數位健康科技臨床研究
  • 新誕生的全方位服務型的虛擬糖尿病診所
  • 參考文獻

附錄A:公司清單

目錄
Product Code: #MDT20003

Overview:

This special technology-based report provides an overview of diabetes, wearable glucose monitoring devices,*smartphone-based digital health technologies, and attempts to answer the question:**can digital health help improve diabetes?

Smartphone-based digital health technologies are expected to transform the diabetes management market over the next decade by substantially improving diabetes outcomes and reducing healthcare costs.*These technologies are engaging and empowering patients, improving glycemic control, and lowering complications.*Digital health technologies are defined in this report as: diabetes smartphone apps integrated with blood glucose monitoring devices (both standard blood glucose meters and continuous glucose monitoring systems) and personalized "virtual diabetes coaching" services.

The adoption of smartphone-based digital health technologies for diabetes management is being driven by:

  • the large and growing prevalence of diabetes
  • heavy patient burden and treatment complexity
  • poorly controlled diabetes
  • spiraling diabetes-related healthcare costs
  • the rise in global smartphone usage and increased accessibility to smartphone-based "telehealth"
  • positive clinical data supporting reduced complications and healthcare costs.

Companies discussed in this report: Abbott, Ascensia Diabetes Care, Dario Health, Dexcom, Glooko, IBM Watson Health, Insulet Corporation, Lark Technologies, LifeScan, Livongo Health, Medtronic, mySugr, Nemaura Medical, Omada Health, Onduo, One Drop, Roche, Sanofi, Senseonics, Tandem Diabetes Care, Virta Health, and Welldoc.

Table of Contents

Executive Summary

  • i. Digital health is transforming diabetes management
  • ii. Benefits
  • iii. Clinical data
  • iv. Limitations
  • v. Security concerns
  • vi. Conclusion
  • vii. Bibliography

1. Diabetes Overview

  • 1.1. Type 1 diabetes: 5% of the diabetes population are insulin dependent
  • 1.2. Type 2 diabetes: 95% of the diabetes population
  • 1.3. Diabetes prevalence: rising by 50% over next 25 years
  • 1.4. Complications: tight glycemic control can prevent complications
  • 1.5. Prevention
  • 1.6. Bibliography

2. New Guidelines for Achieving Glycemic Control

  • 2.1. ADA's target A1c: 2019 Standards of Medical Care in Diabetes
  • 2.2. The importance of self-monitoring of blood glucose
  • 2.3. The DCCT study
  • 2.4. New 2019 ADA guidelines for glycemic targets: time-in-range
  • 2.5. Medtronic's TIR goals
  • 2.6. Bibliography

3. Blood Glucose Monitoring and the Rise of Smartphone-Driven Diabetes Apps

  • 3.1. Ascensia
  • 3.2. DarioHealth
  • 3.3. LifeScan
  • 3.4. Welldoc's BlueStar for diabetes
  • 3.5. Glooko
  • 3.6. mySugr
  • 3.7. Bibliography
  • Exhibit 3-1: Selected standard blood glucose meters and diabetes apps
  • Exhibit 3-2: OneTouch Verio Flex and OneTouch Reveal app
  • Exhibit 3-3: OneTouch Reveal Plus powered by Welldoc's BlueStar technology
  • Exhibit 3-4: Welldoc's BlueStar AI-driven smart diabetes app
  • Exhibit 3-5: Glooko Mobile app
  • Exhibit 3-6: mySugr app

4. Virtual Diabetes Coaching

  • 4.1. Lark Technologies
  • 4.2. Livongo
  • 4.3. Onduo
  • 4.4. One Drop
  • 4.5. Virta Health
  • 4.6. Bibliography
  • Exhibit 4-1: Onduo for diabetes
  • Exhibit 4-2: The One Drop digital diabetes management portfolio
  • Exhibit 4-3: Virta app

5. Revolutionary Continuous Glucose Monitoring Systems

  • 5.1. Abbott
  • 5.2. Dexcom
  • 5.3. Medtronic
  • 5.4. Nemaura Medical
  • 5.5. Senseonics
  • 5.6. Bibliography
  • Exhibit 5-1: Selected continuous glucose monitoring systems with diabetes apps
  • Exhibit 5-2: The FreeStyle Libre CGM 14-day sensor and LibreLink app
  • Exhibit 5-3: The Dexcom G6 CGM System with extended 10-day sensor
  • Exhibit 5-4: Dexcom CLARITY diabetes management software
  • Exhibit 5-5: The Guardian Connect CGM System with Sugar.IQ app
  • Exhibit 5-6: The SugarBEAT system
  • Exhibit 5-7: The Eversense CGM and mobile app

6. Clinical data - Can Digital Health Help Improve Diabetes?

  • 6.1. Meaningful Reduction in HbA1c
  • 6.2. Clinical review of diabetes apps/digital health technologies
  • 6.3. Emerging full-service virtual diabetes clinics
  • 6.4. Bibliography
  • Exhibit 6-1: Selected studies, average reduction in HbA1c with use of diabetes apps and/ or digital app-based coaching programs

Appendix A: company listing